top of page



Biohaven is a commerical-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies designed to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Through everything we do, our goal remains the same - to improve the lives of patients.

For more information on Biohaven Pharmaceuticals visit:

bottom of page